A
GILD icon

Argentarii’s Gilead Sciences GILD Stock Holding History

Argentarii’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
3,539
+152
+4% +$20K 0.14% 125
2026
Q1 		$472K Buy
3,387
+35
+1% +$4.9K 0.17% 118
2025
Q4 		$411K Buy
3,352
+7
+0.2% +$851 0.13% 126
2025
Q3 		$371K Buy
3,345
+3
+0.1% +$341 0.15% 110
2025
Q2 		$371K Sell
3,342
-50
-1% -$5.32K 0.17% 105
2025
Q1 		$380K Buy
3,392
+99
+3% +$10.2K 0.19% 111
2024
Q4 		$304K Buy
+3,293
New +$296K 0.15% 113

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Argentarii's GILD Position: Q2 2026 in Review

Argentarii increased its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, buying an estimated $20K and bringing the position to 3,539 shares worth $480K. The position accounts for 0.14% of the portfolio, ranked #125.

Argentarii first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Argentarii held 3,539 shares of Gilead Sciences worth $480K as of Q2 2026.
  • Argentarii bought 152 Gilead Sciences shares in Q2 2026, an estimated $20K.
  • Gilead Sciences made up 0.14% of Argentarii's portfolio in Q2 2026, its #125 holding.
  • Argentarii first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.